Page 59 - Read Online
P. 59

Page 8 of 10     Latorre-Rodríguez et al. Mini-invasive Surg 2023;7:6  https://dx.doi.org/10.20517/2574-1225.2022.104

               complication but are associated with high morbidity and mortality. The surgeon must be familiar with the
               clinical symptoms and diagnostic methods to detect and treat this complication early under the basic
               principles: correct the anastomotic defect, prevent or treat sepsis, and provide adequate nutritional support.


               Given the complexity and wide variation in the clinical presentation of ALs, there is currently no consensus
               or clinical practice guidelines to direct the appropriate treatment for each patient. The current trend is away
               from aggressive surgical management of ALs, limiting this option to cases of necrosis or uncontrolled sepsis.
               On the contrary, the use of new minimally invasive management technologies, especially E-Vac and SEMS,
               which have shown satisfactory results in the management of non-critical symptomatic cases, is increasing.

               Currently, there are multiple clinical trials underway to identify and apply more robust intraoperative
               preventive techniques, and new technologies for the minimally invasive management of ALs have been
               introduced. Additional study results are expected in the next decade, and new devices for endoscopic
               management of ALs, including hybrid devices (SEMS + E-Vac) and cell and gene therapies, may be adopted;
               however, more preclinical and clinical trials assessing the safety and effectiveness of these therapies are
               required.

               DECLARATION
               Authors’ contributions
               Made substantial contributions to the concept, scope, literature review, writing, and revisions: Mittal SK,
               Latorre-Rodriguez AR


               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.

               Conflicts of interest
               Both authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2023.


               REFERENCES
               1.       Moon SW, Kim JJ, Cho DG, Park JK. Early detection of complications: anastomotic leakage. J Thorac Dis 2019;11:S805-11.  DOI
                   PubMed  PMC
               2.       Kassis ES, Kosinski AS, Ross P Jr, Koppes KE, Donahue JM, Daniel VC. Predictors of anastomotic leak after esophagectomy: an
                   analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg 2013;96:1919-26.  DOI  PubMed
               3.       Fumagalli U, Baiocchi GL, Celotti A, et al. Incidence and treatment of mediastinal leakage after esophagectomy: insights from the
                   multicenter study on mediastinal leaks. World J Gastroenterol 2019;25:356-66.  DOI  PubMed  PMC
               4.       Fabbi M, Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Anastomotic leakage after esophagectomy for esophageal cancer:
                   definitions, diagnostics, and treatment. Dis Esophagus 2021:34.  DOI  PubMed  PMC
   54   55   56   57   58   59   60   61   62   63   64